Latest News for: best in class

Edit

Kalohexis Emerges from Stealth to Advance First- and Best-in-Class Therapeutics Harnessing the Melanocortin System to ...

O'Colly 20 Mar 2026
Kalohexis' lead programs include 710GO, an oral dual melanocortin-3 and-4 receptor (MC3R/MC4R) agonist, a next-generation general obesity treatment; and mifomelatide, a dual MC3R/MC4R antagonist to prevent and treat cachexia in advanced cancers ... .
Edit

Endevica Announces Spinout of Kalohexis to Advance First- and Best-in-Class Therapeutics Harnessing the Melanocortin System ...

O'Colly 20 Mar 2026
Kalohexis' lead programs include 710GO, an oral dual melanocortin-3 and-4 receptor (MC3R/MC4R) agonist, a next-generation general obesity treatment; and mifomelatide, a dual MC3R/MC4R antagonist to prevent and treat cachexia in advanced cancers ... .
Edit

Homethrive Wins 2026 Lighthouse Tech Awards Best in Class for Caregiving Innovation

Hastings Tribune 20 Mar 2026
Award Recognizes Homethrive's Platform for Scalable, Proactive Caregiving Support Delivering Measurable Impact Across the Benefits Ecosystem ... .
Edit

Foundation Risk Partners and ARTDAI Announce Partnership to Deliver Best-In-Class Risk Advisory for Fine Art and Collectibles

PR Newswire 19 Mar 2026
By combining up-to-date market information with advanced analytics, ARTDAI provides its users with best-in-class research and mission-critical market insights. Founded in 2017, ARTDAI has offices in Newmarket and New York City.
Edit

Kalohexis Emerges from Stealth to Advance First- and Best-in-Class Therapeutics Harnessing the Melanocortin System to Treat Obesity and Metabolic Diseases

PR Newswire 19 Mar 2026
By targeting the melanocortin system in a differentiated way, our portfolio of first- and best-in-class drugs offers new hope to millions of people suffering with metabolic diseases.".
Edit

Endevica Announces Spinout of Kalohexis to Advance First- and Best-in-Class Therapeutics Harnessing the Melanocortin System to Treat Obesity and Metabolic Diseases

PR Newswire 19 Mar 2026
By targeting the melanocortin system in a differentiated way, our portfolio of first- and best-in-class drugs offers new hope to millions of people suffering with metabolic diseases.".
Edit

MetaVia Advances GLP-1-Based Obesity Program with IRB Approval for Higher-Dose Phase 1 Studies of DA-1726, a GLP-1 and Glucagon Dual Agonist Demonstrating Best-in-Class Potential for Weight Loss and Glucose Control (Metavia Inc)

Public Technologies 18 Mar 2026
In the Phase 1 multiple ascending dose (MAD) trial in obesity, the 32 mg dose of DA-1726 demonstrated best-in-class potential for weight loss, glucose control, and waist circumference reduction.
Edit

MetaVia Advances GLP-1-Based Obesity Program with IRB Approval for Higher-Dose Phase 1 Studies of DA-1726, a GLP-1 and Glucagon Dual Agonist Demonstrating Best-in-Class Potential for Weight Loss and Glucose Control

PR Newswire 18 Mar 2026
In the Phase 1 multiple ascending dose (MAD) trial in obesity, the 32 mg dose of DA-1726 demonstrated best-in-class potential for weight loss, glucose control, and waist circumference reduction.
Edit

POMA AI Achieves Best-in-Class RAG Chunking and Document Ingestion With 77% Token Reduction vs. Conventional Models

Nasdaq Globe Newswire 16 Mar 2026
Smart hierarchical chunking is the optimal data preparation for vector database embeddings. Smart hierarchical chunking is the optimal data preparation for vector database embeddings ... .
Edit

JAGGAER Honored as a U.S. Best-in-Class Employer by Gallagher

Business Wire 16 Mar 2026
RESEARCH PARK TRIANGLE, N.C.--(BUSINESS WIRE)--JAGGAER has been recognized as a Best-in-Class ...
Edit

JAGGAER Honored as a U.S. Best-in-Class Employer by Gallagher (JAGGAER LLC)

Public Technologies 16 Mar 2026
What Makes JAGGAER Best in Class? ... "This proactive approach to people strategy is what makes JAGGAER a true Best-in-Class Employer." About the Best-in-Class Benchmarking Analysis.
×